Aryldifluoromethylphosphonic acids were transformed into the corresponding phosphonothioic acids via their bis-(2-cyanoethyl) esters for the evaluation of their biological effects on protein tyrosine phosphatase 1B. Difluoro(2-naphthyl)-methylphosphonothioic acid 5d showed better inhibitory potency and higher hydrophobicity than the corresponding difluoromethylenephosphonic acid analogue 1d.
Introduction
Naturally-occurring phosphate derivatives play pivotal roles in various cellular processes including signal transduction. 1 Non-hydrolyzable phosphate mimetics have been studied for the design of potential enzyme inhibitors and probes for the elucidation of biochemical processes. Extensive studies have been devoted to the synthesis and biological evaluation of (α,α-difluoromethylene)phosphonic acid (DFMPA) derivatives 1, as non-hydrolyzable mimetics of phosphates. 2 As a result, many enzyme inhibitors with significant activity have been identified. mimetics of a phosphate ester. 5 Among them, (α,α-difluoromethylene)phosphonothioic acid (DFMPTA) derivatives, 2, featuring a less-polar phosphorus-sulfur bond, 6 are proposed as a class of non-hydrolyzable phosphate mimetics possessing unique and useful properties. 7 However, the physical and biological properties of DFMPTA compounds have not been studied extensively, owing to the lack of efficient synthetic methods. 
Figure 1
In the search for DFMPA-based inhibitors of protein tyrosine phosphatases (PTPs), which are key regulatory enzymes in many cellular processes such as cell proliferation and differentiation, we and others have identified the novel DFMPA derivatives 1b, 1d and 1e, which acted as small molecular inhibitors for protein tyrosine phosphatase 1B (PTP-1B). 4, 5, 8 As a part of our program to create small molecular inhibitors of PTP-1B with a better inhibition profile, we became interested in the synthesis and biological evaluation of their DFMPTA analogues. In this paper, we describe an efficient method for the transformation of DFMPAs into DFMPTAs. We also report the results of preliminary studies on the inhibitory activity of the DFMPTA analogues against PTP-1B.
Figure 2
Results and Discussion and the subsequent Pd-catalyzed de-allylation reaction, as shown in Scheme 1. 9 However, it was rather difficult to obtain reproducible yields in the de-allylation step in this sequence. 
Scheme 1
Therefore, in the present studies, we examined an alternative method for the synthesis of 5, in which diethyl phosphonates 6a-e were first transesterified with 2-cyanoethanol, 11 followed by sequential thionylation and deprotection of the 2-cyanoethyl group as shown in Scheme 2. The starting diethyl phosphonates 6a-e were prepared according to the method described previously, and transformed into the corresponding free acids 1a-e by TMSBr-mediated deprotection. 8, 9, 12 Treatment of 1a-e with oxalyl chloride in boiling CH 2 Cl 2 in the presence of N,Ndimethylaminopyridine (DMAP) and DMF for 10 h gave the corresponding dichlorides, which were subsequently treated with 2-cyanoethanol in pyridine to give the bis-(2-cyanoethyl) esters 7a-e in 72-91% yield. Thionylation of 7a-e with Lawesson's reagent [2,4-bis-(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide] in toluene at 100 °C gave 8a-e in 47-91% yield. Deprotection of the 2-cyanoethyl group was achieved with K 2 CO 3 in MeOH to give the potassium salts 9a-e in 47-76% yield. Acidification of 9d with 1M HCl, followed by extraction with ether, gave the free acid 5d in 83% yield. 
Physical properties and biological effects
To examine the features of DFMPTAs in their physical properties and biological effects, we first determined the octanol/water distribution coefficient (D) of 5d by a shake-flask method. 13 The D value of the phosphonothioic acid 5d was estimated to be 0.89 at 25 °C, and is approximately 5-times larger than that (0.18) of the corresponding phosphonic acid analogue 1d. Consequently, 5d is sufficiently lipophilic to be extracted with organic solvents such as ether, whereas 1d could not be extracted with ether from the aqueous solution. The second dissociation constants (pKa 2 ) of 5d and 1d were also determined to be 4.5 and 5.4, respectively, by a standard titration method. These results reveal that 5d would exist mainly in the dianionic form at cellular pH (6.5) as in the case of 1d, but might possess the property of enhancing cellular penetration, owing to its relatively high hydrophobicity. 14, 15 With these observations in mind, we next examined the inhibitory activity of 5d against PTP-1B in comparison with that of 1d. The results are shown in Table 1 . The IC 50 of 5d was determined to be 418.5 µM, which shows that 5d possesses a slightly higher inhibitory potency than 1d. While the inhibitor 5d is slightly labile at room temperature, the corresponding potassium salt 9d was found to be stable and shows approximately the same inhibitory potency as 1d. Therefore, the inhibitory potencies for the DFMPTA analogues of 1b and 1e were evaluated by using their potassium salts 9b and 9e. However, 9b and 9e were 5-and 11-times, respectively, poorer inhibitors than their DFMPA analogues 1b and 1e. In summary, we have developed an efficient method for the preparation of novel (α,α -difluoromethylene)phosphonothioic acids from (α,α-difluoromethylene)phosphonic acids through thionylation and deprotection of their bis-(2-cyanoethyl) esters. The method allowed us to synthesize DFMPTA-derived aromatic compounds that possess moderate inhibitory potency against PTP-1B.
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General Procedures. All melting points are uncorrected. All reactions were carried out under a nitrogen atmosphere. NMR data were obtained on a Bruker DPX 400 for a solution in the indicated solvent, unless otherwise specified. as an internal reference. PTP-1B was purchased from Upstate Biotech. Inc. "RT" denotes room temperature.
Typical example of preparation of aryldifluoromethylphosphonic acids. Difluoro-(4-methyl-phenyl)methylphosphonic acid (1a)
To a stirred solution of 6a 12 (3.14 g, 11.3 mmol) in CH 2 Cl 2 (23 mL) was added TMSBr 
Typical example of preparation of bis-(2-cyanoethyl) phosphonates. bis-(2-Cyanoethyl) difluoro(4-methylphenyl)methylphosphonate (7a)
To a suspension of 1a (10 mmol, 2.22 g) in CH 2 Cl 2 (20 mL) containing DMF (78 mg, 1 mmol) and DMAP (122 mg, 1 mmol) was added oxalyl chloride (3.1 mL, 35 mmol) over a period of several minutes. The mixture was heated under reflux for 10 h, then concentrated by rotary evaporation to give the crude phosphonic acid dichloride. To a solution of the crude phosphonic acid dichloride in THF (5 mL) was added a solution of 2-cyanoethanol (1.7 mL, 25 mmol) and pyridine (2.0 mL, 25 mmol) in THF (5 mL) at 0 °C. After being stirred for 30 min at 0 °C, then 10 h at RT, the mixture was poured into saturated aq. NH 4 Cl and extracted with chloroform. The extracts were washed with brine, dried (MgSO 4 ) and concentrated. The residue was chromatographed on silica gel (hexane:EtOAc=1:1) to give 11a (2.39 g, 73%) as an oil. 1 
Bis-(2-cyanoethyl) {3-[bis-(methylsulfonyl)amino]-4-[(E)-2-phenylethenyl]phenyl} (difluoro)-methylphosphonate (7e).
Prepared from 1e (4.53 g, 9.4 mmol). Column chromatography on silica gel (hexane:EtOAc=1:1) gave 7e (3.91 g, 71%) as colorless crystals (mp 150-151 °C). 
Typical example of thionylation of bis-(2-cyanoethyl) phosphonates with Lawesson's reagent. O,O-Bis-(2-cyanoethyl) difluoro(4-methylphenyl)methylphosphonothioate (8a).
A solution of 7a (2.41 g, 7.34 mmol) and Lawesson's reagent (1.78 g, 4.4 mmol) in toluene (7 mL) was heated at 100 °C for 30 min. After cooling to RT, the resulting precipitates were filtered off. The filtrates were evaporated and the residue was chromatographed on silica gel (hexane:EtOAc=4:1) to give 8a (1.3 g, 52%) as an oil. 1 -(2-cyanoethyl) [1,1'-biphenyl]-3-yl(difluoro)methylphosphonothioate (8b) . Prepared from 7b (4.62 g, 11.8 mmol). Purification by column chromatography on silica gel (hexane:EtOAc=6:1) gave 8b (2.3 g, 47%) as an oil. 1 Typical deprotection procedure for the bis-(2-cyanoethyl) phosphonothioates Potassium difluoro(4-methylphenyl)methylphosphonothioate (9a). To a stirred solution of 8a (1.15g, 3.34 mmol) in MeOH (15 mL) was added K 2 CO 3 (1.38 g, 10.1 mmol). After being stirred at RT for 2.5 h, the mixture was diluted with water and extracted with ether (3x10 mL). The volatile component of the aqueous extracts was removed in vacuo and the resulting precipitates were purified by reversed-phase column chromatography on ODS. Elution with water gave 9a (798 mg, 76%) as colorless crystals (mp>250 °C). The spectroscopic data of 9a were identical to those of the authentic sample prepared previously. Potassium [1,1´-biphenyl]-3-yl(difluoro)methylphosphonothioate (9b). Prepared from 8b (2.06 g, 5.07 mmol). Purification by column chromatography on ODS (water) gave 9b (1.38 g, 72%) as colorless crystals (mp>250 °C). The spectroscopic data of 9b were identical to those of the authentic sample prepared previously.
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Potassium difluoro(1-naphthyl)methylphosphonothioate (9c). Prepared from 8c (910 mg, 2.39 mmol). Purification by column chromatography on ODS (water) gave 9c (400 mg, 47%) as colorless crystals (mp>250 °C). The spectroscopic data of 9c were identical to those of the authentic sample prepared previously.
Potassium difluoro(2-naphthyl)methylphosphonothioate (9d). Prepared from 8d (1.22 g, 3.21 mmol). Purification by column chromatography on ODS (water) gave 9d (843 mg, 75%) as colorless crystals (mp>250 °C). The spectroscopic data of 9d were identical to those of the authentic sample prepared previously. Assay and inhibition of PTP-1B. PTP-1B activity was assessed according to the manufacturer's instructions. Briefly, the activity of PTP-1B was assessed at 25 °C in 96-well plates with pnitrophenyl phosphate (pNPP) as substrate. The assay mixture contained 5 µL of 40 mM NiCl 2 in water, 5 mM of a bovine serum albumin solution (5 mg/mL in water), 5 µL of PTP-1B-agaroses (0.05 units) and 65 µL of 50 mM Tris-HCl buffer (pH 7.0)/0.1 mM CaCl 2 that, if indicated, contained various concentrations of inhibitor, and pre-incubation followed for 15 min. The enzyme reaction was started by the addition of 120 µL of a pNPP solution (1.5 mg/mL in 50 mM Tris-HCl buffer). After incubation for 30 min, the reaction was stopped by adding 20 mL of a 13% (w/v) K 2 HPO 4 solution, and the absorbance at 405 nm was measured. The non-enzymatic hydrolysis of pNPP was corrected by measuring the control without the addition of enzyme. IC 50 values were determined as the concentration of compounds that give 50% of the control enzyme activity. The experiments were carried out in triplicate at 5 or 8 different inhibitor concentrations. The inhibitor concentrations were plotted as the y-axis and the remaining activity (%) as the x-axis, and the concentration of inhibitor that give a 50% inhibition was calculated, using the curve-fit equation, CA-Cricket Graph III.
